Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 2/20 | 0.56 |
| ▸ | CA1 | P00915 | 2/20 | 0.56 |
| ▸ | CA2 | P00918 | 2/20 | 0.56 |
| ▸ | ACP1 | P24666 | 3/20 | 0.55 |
| ▸ | IL1RN | P18510 | 1/20 | 0.54 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | PTPRB | P23467 | 5/20 | 0.47 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.47 |
| ▸ | PTPRA | P18433 | 1/20 | 0.47 |
| ▸ | PGR | P06401 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 2/20 | 0.45 |
| ▸ | CA9 | Q16790 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | TMPRSS6 | Q8IU80 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL6746153 | 0.97 | CA2 (0.58) | KEAP1CA1CA2ACP1IL1RN | |
| SCHEMBL146561 | 0.97 | CA2 (0.58) | KEAP1CA1CA2ACP1IL1RN | |
| SCHEMBL28176614 | 0.95 | CA2 (0.56) | KEAP1CA1CA2ACP1IL1RN | |
| Hydrochloric Acid SCHEMBL5069950 | 0.95 | CA2 (0.56) | KEAP1CA1CA2ACP1IL1RN | |
| Methane SCHEMBL3339448 | 0.95 | CA2 (0.56) | KEAP1CA1CA2ACP1IL1RN | |
| SCHEMBL3213812 | 0.95 | CA2 (0.56) | KEAP1CA1CA2ACP1IL1RN | |
| SCHEMBL29756025 | 0.95 | CA2 (0.56) | KEAP1CA1CA2ACP1IL1RN | |
| Formaldehyde SCHEMBL28212330 | 0.93 | CA2 (0.54) | KEAP1CA1CA2ACP1IL1RN | |
| Sulfamate SCHEMBL11079904 | 0.91 | CA1 (0.64) | KEAP1CA1CA2ACP1IL1RN | |
| Chloromethane SCHEMBL11386742 | 0.91 | KEAP1 (0.58) | KEAP1CA1CA2ACP1IL1RN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1919440-A2 | AGENT FOR SIMULTANEOUS LIGHTENING AND COLORING OF KERATIN FIBRES CONTAINING A SULFAMATE BLEACH BOOSTER | The Procter and Gamble Company (US) | 2008-05-14 | — | — | EP | claimed |
| EP-1919439-A2 | PROCESS FOR BLEACHING KERATIN FIBERS | The Procter and Gamble Company (US) | 2008-05-14 | — | — | EP | claimed |
| US-20070231283-A1 | Process for bleaching keratin fibers | PROCTER & GAMBLE COMPANY, THE | 2007-10-04 | — | — | US | claimed |
| US-20070067925-A1 | Agent for simultaneously lightening and coloring of fibers | PROCTER & GAMBLE COMPANY, THE | 2007-03-29 | — | — | US | claimed |
| WO-2007026327-A2 | PROCESS FOR BLEACHING KERATIN FIBERS | THE PROCTER & GAMBLE COMPANY (US) | 2007-03-08 | — | — | WO | claimed |
| WO-2007026328-A2 | AGENT FOR SIMULTANEOUS LIGHTENING AND COLORING OF KERATIN FIBRES CONTAINING A SULFAMATE BLEACH BOOSTER | THE PROCTER & GAMBLE COMPANY (US) | 2007-03-08 | — | — | WO | claimed |
| EP-1759685-A1 | Agent for simultaneous lightening and coloring of keratin fibres containing a sulfamate bleach booster | Wella Aktiengesellschaft (DE) | 2007-03-07 | — | — | EP | claimed |
| EP-1759684-A1 | Process for bleaching keratin fibers | Wella Aktiengesellschaft (DE) | 2007-03-07 | — | — | EP | claimed |
| CN-109771421-A | The method for treating vascular leak syndrome | 爱尔皮奥治疗有限公司 | 2019-05-21 | — | — | CN | disclosed |
| CN-108635350-A | The method for treating vascular leak syndrome | 爱尔皮奥治疗有限公司 | 2018-10-12 | — | — | CN | disclosed |
| CN-105412094-A | Compounds, Compositions, And Methods For Preventing Metastasis Of Cancer Cells | AKEBIA THERAPEUTICS INC | 2016-03-23 | — | — | CN | disclosed |
| CN-105307498-A | Compositions, formulations and methods for treating ocular diseases | AERPIO THERAPEUTICS INC | 2016-02-03 | — | — | CN | disclosed |
| EP-1919440-A2 | AGENT FOR SIMULTANEOUS LIGHTENING AND COLORING OF KERATIN FIBRES CONTAINING A SULFAMATE BLEACH BOOSTER | The Procter and Gamble Company (US) | 2008-05-14 | — | — | EP | disclosed |
| EP-1919439-A2 | PROCESS FOR BLEACHING KERATIN FIBERS | The Procter and Gamble Company (US) | 2008-05-14 | — | — | EP | disclosed |
| US-20070231283-A1 | Process for bleaching keratin fibers | PROCTER & GAMBLE COMPANY, THE | 2007-10-04 | — | — | US | disclosed |
| US-20070067925-A1 | Agent for simultaneously lightening and coloring of fibers | PROCTER & GAMBLE COMPANY, THE | 2007-03-29 | — | — | US | disclosed |
| WO-2007026328-A2 | AGENT FOR SIMULTANEOUS LIGHTENING AND COLORING OF KERATIN FIBRES CONTAINING A SULFAMATE BLEACH BOOSTER | THE PROCTER & GAMBLE COMPANY (US) | 2007-03-08 | — | — | WO | disclosed |
| WO-2007026327-A2 | PROCESS FOR BLEACHING KERATIN FIBERS | THE PROCTER & GAMBLE COMPANY (US) | 2007-03-08 | — | — | WO | disclosed |
| EP-1759685-A1 | Agent for simultaneous lightening and coloring of keratin fibres containing a sulfamate bleach booster | Wella Aktiengesellschaft (DE) | 2007-03-07 | — | — | EP | disclosed |
| EP-1759684-A1 | Process for bleaching keratin fibers | Wella Aktiengesellschaft (DE) | 2007-03-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070067925-A1 | Agent for simultaneously lightening and coloring of fibers | KIT, KRT18, H1-5 | KEAP1 307/4885CA1 434/4885CA2 132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.